Search clinical trials for: CDR132L

Total 4 results

Cardior Pharmaceuticals GmbH

Active, not recruiting

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction (HF-REVERT)

Myocardial Infarction, Acute | Heart Failure, Left Sided

Netherlands, Spain, Hungary, Germany, United Kingdom, Czechia, Poland, Greece
Cardior Pharmaceuticals GmbH

Completed

Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

Heart Failure

United Kingdom
Cardior Pharmaceuticals GmbH

Not yet recruiting

Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy (REMOD-REVERT)

Heart Failure With Preserved Ejection Fraction
National University Hospital, Singapore

Unknown

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Cancer

Singapore

3

Subscribe